Non-overlapping progesterone receptor cistromes contribute to cell-specific transcriptional outcomes

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Clarke, Christine L ^a   Graham, J Dinny ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; GESTAGEN; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; PROGESTERONE RECEPTOR; DNA; FOXA1 PROTEIN, HUMAN; PROGESTERONE; TRANSCRIPTOME;

ARTICLE; BINDING SITE; BREAST CANCER; BREAST CELL; CANCER CELL; CELL SPECIFICITY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE INTERACTION; TRANSCRIPTION REGULATION; BREAST; BREAST TUMOR; CELL LINE; CYTOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PROTEIN BINDING; TUMOR CELL LINE;

BREAST; BREAST NEOPLASMS; CELL LINE; CELL LINE, TUMOR; DNA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; HUMANS; PROGESTERONE; PROGESTINS; PROTEIN BINDING; RECEPTORS, PROGESTERONE; TRANSCRIPTOME;

EID: 84860163258     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035859     Document Type: Article

References (65)

1. Hubler TR, Scammell JG, (2004) Intronic hormone response elements mediate regulation of FKBP5 by progestins and glucocorticoids. Cell Stress Chaperones 9: 243-252.
2. Lieberman BA, Bona BJ, Edwards DP, Nordeen SK, (1993) The constitution of a progesterone response element. Mol Endocrinol 7: 515-527.
3. Nelson CC, Hendy SC, Shukin RJ, Cheng H, Bruchovsky N, et al. (1999) Determinants of DNA sequence specificity of the androgen, progesterone, and glucocorticoid receptors: evidence for differential steroid receptor response elements. Mol Endocrinol 13: 2090-2107.
4. Onate SA, Tsai SY, Tsai MJ, O'Malley BW, (1995) Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270: 1354-1357.
5. Liu Z, Wong J, Tsai SY, Tsai MJ, O'Malley BW, (2001) Sequential recruitment of steroid receptor coactivator-1 (SRC-1) and p300 enhances progesterone receptor-dependent initiation and reinitiation of transcription from chromatin. Proc Natl Acad Sci U S A 98: 12426-12431.
6. McKenna NJ, O'Malley BW, (2002) Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108: 465-474.
7. Scarpin KM, Graham JD, Mote PA, Clarke CL, (2009) Progesterone action in human tissues: regulation by progesterone receptor (PR) isoform expression, nuclear positioning and coregulator expression. Nucl Recept Signal 7: e009.
8. Vicent GP, Zaurin R, Nacht AS, Li A, Font-Mateu J, et al. (2009) Two chromatin remodeling activities cooperate during activation of hormone responsive promoters. PLoS Genet 5: e1000567.
9. Vicent GP, Ballare C, Zaurin R, Saragueta P, Beato M, (2006) Chromatin remodeling and control of cell proliferation by progestins via cross talk of progesterone receptor with the estrogen receptors and kinase signaling pathways. Ann N Y Acad Sci 1089: 59-72.
10. Vicent GP, Nacht AS, Zaurin R, Ballare C, Clausell J, et al. (2010) Minireview: role of kinases and chromatin remodeling in progesterone signaling to chromatin. Mol Endocrinol 24: 2088-2098.
11. Vicent GP, Zaurin R, Nacht AS, Font-Mateu J, Le Dily F, et al. (2010) Nuclear factor 1 synergizes with progesterone receptor on the mouse mammary tumor virus promoter wrapped around a histone H3/H4 tetramer by facilitating access to the central hormone-responsive elements. J Biol Chem 285: 2622-2631.
12. Friedman JR, Kaestner KH, (2006) The Foxa family of transcription factors in development and metabolism. Cell Mol Life Sci 63: 2317-2328.
13. Bernardo GM, Lozada KL, Miedler JD, Harburg G, Hewitt SC, et al. (2010) FOXA1 is an essential determinant of ERalpha expression and mammary ductal morphogenesis. Development 137: 2045-2054.
14. Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, et al. (2006) Genome-wide analysis of estrogen receptor binding sites. Nat Genet 38: 1289-1297.
15. Hurtado A, Holmes KA, Ross-Innes CS, Schmidt D, Carroll JS, (2011) FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nat Genet 43: 27-33.
16. Lupien M, Eeckhoute J, Meyer CA, Wang Q, Zhang Y, et al. (2008) FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 132: 958-970.
17. Wang Q, Li W, Liu XS, Carroll JS, Janne OA, et al. (2007) A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. Mol Cell 27: 380-392.
18. Cicatiello L, Addeo R, Sasso A, Altucci L, Petrizzi VB, et al. (2004) Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cyclin D1 to its own gene promoter. Mol Cell Biol 24: 7260-7274.
19. Kushner PJ, Agard DA, Greene GL, Scanlan TS, Shiau AK, et al. (2000) Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol 74: 311-317.
20. Tseng L, Tang M, Wang Z, Mazella J, (2003) Progesterone receptor (hPR) upregulates the fibronectin promoter activity in human decidual fibroblasts. DNA Cell Biol 22: 633-640.
21. Beguelin W, Diaz Flaque MC, Proietti CJ, Cayrol F, Rivas MA, et al. (2010) Progesterone receptor induces ErbB-2 nuclear translocation to promote breast cancer growth via a novel transcriptional effect: ErbB-2 function as a coactivator of Stat3. Mol Cell Biol 30: 5456-5472.
22. Faivre EJ, Daniel AR, Hillard CJ, Lange CA, (2008) Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors. Mol Endocrinol 22: 823-837.
23. Graham JD, Clarke CL, (1997) Physiological action of progesterone in target tissues. Endocr Rev 18: 502-519.
24. Clarke CL, Sutherland RL, (1990) Progestin regulation of cellular proliferation. Endocr Rev 11: 266-301.
25. Longacre TA, Bartow SA, (1986) A correlative morphologic study of human breast and endometrium in the menstrual cycle. Am J Surg Pathol 10: 382-393.
26. Ace CI, Okulicz WC, (2004) Microarray profiling of progesterone-regulated endometrial genes during the rhesus monkey secretory phase. Reprod Biol Endocrinol 2: 54.
27. Borthwick JM, Charnock-Jones DS, Tom BD, Hull ML, Teirney R, et al. (2003) Determination of the transcript profile of human endometrium. Mol Hum Reprod 9: 19-33.
28. Graham JD, Yager ML, Hill HD, Byth K, O'Neill GM, et al. (2005) Altered progesterone receptor isoform expression remodels progestin responsiveness of breast cancer cells. Mol Endocrinol 19: 2713-2735.
29. Kao LC, Tulac S, Lobo S, Imani B, Yang JP, et al. (2002) Global gene profiling in human endometrium during the window of implantation. Endocrinology 143: 2119-2138.
30. Richer JK, Jacobsen BM, Manning NG, Abel MG, Wolf DM, et al. (2002) Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J Biol Chem 277: 5209-5218.
31. Beral V, Million Women Study C, (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362: 419-427.
32. Beral V, Reeves G, Bull D, Green J, (2011) Breast Cancer Risk in Relation to the Interval Between Menopause and Starting Hormone Therapy. J Natl Cancer Inst 103: 296-305.
33. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, et al. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288: 321-333.
34. Chlebowski RT, Anderson GL, Gass M, Lane DS, Aragaki AK, et al. (2010) Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA 304: 1684-1692.
35. Graham JD, Mote PA, Salagame U, van Dijk JH, Balleine RL, et al. (2009) DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast. Endocrinology 150: 3318-3326.
36. Langmead B, Trapnell C, Pop M, Salzberg SL, (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10: R25.
37. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B, (2008) Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 5: 621-628.
38. Roschke AV, Tonon G, Gehlhaus KS, McTyre N, Bussey KJ, et al. (2003) Karyotypic complexity of the NCI-60 drug-screening panel. Cancer Res 63: 8634-8647.
39. Tang Q, Chen Y, Meyer C, Geistlinger T, Lupien M, et al. (2011) A comprehensive view of nuclear receptor cancer cistromes. Cancer Res 71: 6940-6947.
40. Wang D, Garcia-Bassets I, Benner C, Li W, Su X, et al. (2011) Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA. Nature 474: 390-394.
41. Joseph R, Orlov YL, Huss M, Sun W, Kong SL, et al. (2010) Integrative model of genomic factors for determining binding site selection by estrogen receptor-alpha. Mol Syst Biol 6: 456.
42. Bravieri R, Shiyanova T, Chen TH, Overdier D, Liao X, (1997) Different DNA contact schemes are used by two winged helix proteins to recognize a DNA binding sequence. Nucleic Acids Res 25: 2888-2896.
43. Cirillo LA, Zaret KS, (2007) Specific interactions of the wing domains of FOXA1 transcription factor with DNA. J Mol Biol 366: 720-724.
44. Pierrou S, Hellqvist M, Samuelsson L, Enerback S, Carlsson P, (1994) Cloning and characterization of seven human forkhead proteins: binding site specificity and DNA bending. EMBO J 13: 5002-5012.
45. Reddy TE, Pauli F, Sprouse RO, Neff NF, Newberry KM, et al. (2009) Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation. Genome Res 19: 2163-2171.
46. Welboren WJ, van Driel MA, Janssen-Megens EM, van Heeringen SJ, Sweep FC, et al. (2009) ChIP-Seq of ERalpha and RNA polymerase II defines genes differentially responding to ligands. EMBO J 28: 1418-1428.
47. Macquarrie KL, Fong AP, Morse RH, Tapscott SJ, (2011) Genome-wide transcription factor binding: beyond direct target regulation. Trends Genetics 27: 141-148.
48. Krum SA, Miranda-Carboni GA, Lupien M, Eeckhoute J, Carroll JS, et al. (2008) Unique ERalpha cistromes control cell type-specific gene regulation. Molecular Endocrinology 22: 2393-2406.
49. So AY, Chaivorapol C, Bolton EC, Li H, Yamamoto KR, (2007) Determinants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor. PLoS Genet 3: e94.
50. Bolton EC, So AY, Chaivorapol C, Haqq CM, Li H, et al. (2007) Cell- and gene-specific regulation of primary target genes by the androgen receptor. Genes Dev 21: 2005-2017.
51. Yin P, Roqueiro D, Huang L, Owen JK, Xie A, et al. (2012) Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. PLoS One 7: e29021.
52. Rayasam GV, Elbi C, Walker DA, Wolford R, Fletcher TM, et al. (2005) Ligand-specific dynamics of the progesterone receptor in living cells and during chromatin remodeling in vitro. Mol Cell Biol 25: 2406-2418.
53. Belikov S, Astrand C, Wrange O, (2009) FoxA1 binding directs chromatin structure and the functional response of a glucocorticoid receptor-regulated promoter. Mol Cell Biol 29: 5413-5425.
54. Garcia-Bassets I, Kwon Y-S, Telese F, Prefontaine GG, Hutt KR, et al. (2007) Histone methylation-dpendent mechanisms impose ligand dependency for gene activation by nuclear receptors. Cell 128: 505-518.
55. Metzger E, Wissmann M, Yin N, Muller JM, Schneider R, et al. (2005) LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 437: 436-439.
56. John S, Sabo PJ, Thurman RE, Sung MH, Biddie SC, et al. (2011) Chromatin accessibility pre-determines glucocorticoid receptor binding patterns. Nat Genet 43: 264-268.
57. Murtagh J, Martin F, Gronostajski RM, (2003) The Nuclear Factor I (NFI) gene family in mammary gland development and function. J Mammary Gland Biol Neoplasia 8: 241-254.
58. Streuli CH, Edwards GM, Delcommenne M, Whitelaw CB, Burdon TG, et al. (1995) Stat5 as a target for regulation by extracellular matrix. J Biol Chem 270: 21639-21644.
59. Clarke CL, Zaino RJ, Feil PD, Miller JV, Steck ME, et al. (1987) Monoclonal antibodies to human progesterone receptor: characterization by biochemical and immunohistochemical techniques. Endocrinology 121: 1123-1132.
60. Ji H, Jiang H, Ma W, Johnson DS, Myers RM, et al. (2008) An integrated software system for analyzing ChIP-chip and ChIP-seq data. Nat Biotechnol 26: 1293-1300.
61. Heinz S, Benner C, Spann N, Bertolino E, Lin YC, et al. (2010) Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 38: 576-589.
62. Bailey TL, Williams N, Misleh C, Li WW, (2006) MEME: discovering and analyzing DNA and protein sequence motifs. Nucleic Acids Res 34: W369-373.
63. Bailey TL, Boden M, Whitington T, Machanick P, (2010) The value of position-specific priors in motif discovery using MEME. BMC Bioinformatics 11: 179.
64. Reich M, Liefeld T, Gould J, Lerner J, Tamayo P, et al. (2006) GenePattern 2.0. Nat Genet 38: 500-501.
65. Graham JD, Yeates C, Balleine RL, Harvey SS, Milliken JS, et al. (1995) Characterization of progesterone receptor A and B expression in human breast cancer. Cancer Res 55: 5063-5068.